JP Morgan Chase
APMD

JP Morgan Chase’s Apnimed Inc APMD Stock Holding History

JP Morgan Chase’s Portfolio APMD Stock Details APMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$34.4M Buy
+1,438,577
New +$38.7M ﹤0.01% 1757

Other funds holding APMD

Alpha Wave Global
Alpha Wave Global New York $4.27B AUM 12.79% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $1.08B AUM 14.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Sectoral Asset Management
Sectoral Asset Management Montreal, Quebec, Canada $157M AUM 41.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

JP Morgan Chase's APMD Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Apnimed Inc (APMD) in Q3 2026: 1,438,577 shares worth $34.4M. The stake represents ﹤0.01% of the portfolio and ranks #1757 among its holdings.

42 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • JP Morgan Chase held 1,438,577 shares of Apnimed Inc worth $34.4M as of Q3 2026.
  • Apnimed Inc was a new JP Morgan Chase position in Q3 2026.
  • Apnimed Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #1757 holding.
  • 42 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.